• OUR MISSION

    Improve the health of the people of Wisconsin by supporting and strengthening physicians' ability to practice high-quality patient care in a changing environment.

Medigram: June 28, 2018

Editor’s Note: Wisconsin Medical Society offices will be closed July 4, due to Independence Day. Unless breaking news occurs, there will be no Medigram on July 5. We thank you for your membership and wish you a safe and happy Fourth of July.

Top Story

State Supreme Court restores cap on damages
In a highly anticipated decision with significant potential ramifications for Wisconsin’s medical liability environment, the Wisconsin Supreme Court yesterday restored Wisconsin’s cap on noneconomic damages in medical liability actions. Read more.

News Briefs

Impact of Mayo decision focus of new WisMed OnCall
Yesterday’s decision by the Wisconsin Supreme Court in Mayo vs. the Injured Patients and Families Compensation Fund reinstates the cap on noneconomic damages in medical liability cases. Read more.

Wisconsin Medicare beneficiaries receiving new cards
The Centers for Medicare and Medicaid Services (CMS) has begun issuing new Medicare cards to Wisconsin residents. Read more.

Schwartzstein receives Presidential Citation
Alan Schwartzstein, MD, FAAFP, was awarded the Wisconsin Medical Society’s Presidential Citation during its Board of Directors meeting Saturday in Madison. Read more.

Society of Neurological Surgeons honors Madison physician
Wisconsin Medical Society member Robert Dempsey, MD, was honored by the Society of Neurological Surgeons (SNS) as the third recipient of its Medical Student Teaching Award. Read more.


Recommended by Wisconsin Medical Society CEO Bud Chumbley, MD, MBA

Copay coupons for prescription drugs have become increasingly common since they were introduced in the mid-2000s. While they might seem benign, their impact on the cost of health care is anything but, according to research from Christopher Ody, a research assistant professor of strategy at the Kellogg School of Management at Northwestern University.

In “Prescription drug coupons actually increase healthcare spending by billions,” Ody and coauthors Leemore Dafny of Harvard Business School and Matt Schmitt of the UCLA Anderson School of Business discuss the effect of copay coupons on brand-name drugs for which a generic equivalent was available. Based on their findings, what may seem like a good deal, in fact allows companies to continue raising prescription drug prices without decreasing demand, and insurance companies and, ultimately patients, pay the price.